Value proposition

Developing a new device based upon airborne ultrasounds improving diagnosis and follow-up of lung and cardiac diseases.

AUSTRAL Dx is a French start-up developing a new imaging technology based upon airborne ultrasounds which will map vibrations originating from the lungs (directly or via vocal fremitus) or the heartbeat and appearing on the surface of the skin with a precision of 1 micron. This new device will accelerate and improve the diagnosis and the follow-up of lung and cardiac diseases.